G Omura
About
In The Last Decade
G Omura
25 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 82
- Oncology 820
- Reproductive Medicine 738
- Surgery 704
- Pulmonary and Respiratory Medicine 592
- Obstetrics and Gynecology 561
Countries citing papers authored by G Omura
This map shows the geographic impact of G Omura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Omura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Omura more than expected).
Fields of papers citing papers by G Omura
This network shows the impact of papers produced by G Omura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Omura. The network helps show where G Omura may publish in the future.
Co-authorship network of co-authors of G Omura
This figure shows the co-authorship network connecting the top 25 collaborators of G Omura. A scholar is included among the top collaborators of G Omura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Omura. G Omura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Axopodial degradation in the heliozoon Raphidiophrys contractilis: a novel bioassay system for detecting heavy metal toxicity in an aquatic environment. | 2 |
| 2 | 36 | |
| 3 | 208 | |
| 4 | A RANDOMIZED TRIAL OF CISPLATIN VERSUS CISPLATIN+ MITOLACTOL VERSUS CISPLATIN + ISOFOSPHAMIDE IN ADVANCED SQUAMOUS CARCINOMA OF THE CERVIX BY THE GYNECOLOGIC ONCOLOGIC GROUP | 2 |
| 5 | 121 | |
| 6 | 51 | |
| 7 | 370 | |
| 8 | Ondansetron (GR 38032F): a novel antiemetic effective in patients receiving a multiple-day regimen of cisplatin chemotherapy. | 11 |
| 9 | 69 | |
| 10 | 265 | |
| 11 | 56 | |
| 12 | 98 | |
| 13 | 99 | |
| 14 | 67 | |
| 15 | 16 | |
| 16 | 36 | |
| 17 | 166 | |
| 18 | 69 | |
| 19 | 257 | |
| 20 | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.